METASTATIC RENAL CELL CARCINOMA
Clinical trials for METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo shows promise in kidney cancer battle
Disease control CompletedThis phase 3 trial compared a combination of two immunotherapy drugs (nivolumab and ipilimumab) against the standard drug sunitinib in over 1,000 people with untreated advanced or metastatic kidney cancer. The study measured how well the tumors shrank, how long patients lived wit…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Immunotherapy duo shows promise for Tough-to-Treat kidney cancer
Disease control CompletedThis phase 2 trial tested whether combining two immunotherapy drugs, nivolumab and ipilimumab, works better than standard treatments for people with advanced non-clear cell kidney cancer. About 316 participants received either the drug combo or standard therapy. The main goal was…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Kidney cancer study questions need for surgery in advanced cases
Disease control CompletedThis phase 3 trial tested whether removing the kidney (nephrectomy) before taking the drug sunitinib helps people with metastatic kidney cancer live longer compared to taking sunitinib alone. 452 patients were randomly assigned to either surgery plus sunitinib or sunitinib only. …
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 13:27 UTC
-
New scan could reveal cancer drug success in days, not months
Diagnosis CompletedThis pilot study tested a special PET scan method to see if it could detect early signs that targeted therapy is working for genitourinary cancer. Eleven patients had scans before and two weeks after starting treatment. The goal was to see if changes in tumor blood flow could pre…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Large study reveals Real-World outcomes of immunotherapy in advanced kidney cancer
Knowledge-focused CompletedThis study reviewed medical records of 494 adults with advanced kidney cancer who received immunotherapy as their first treatment. Researchers looked at how long patients stayed on treatment, how they responded, and survival rates. The goal was to understand which treatment combi…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Gene hunt: why does sunitinib work differently in kidney cancer patients?
Knowledge-focused CompletedThis completed study enrolled 43 people with kidney cancer who were starting sunitinib (Sutent). Researchers measured the drug's level in the blood and checked for genetic differences that might affect how the body processes it. The goal was to understand why sunitinib levels var…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC